You are here

Big pharma turns to artificial intelligence to speed up drug discovery process

London

THE world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with Glaxo-SmithKline unveiling a new US$43 million deal in the field on Sunday.

Other pharmaceutical giants including Merck & Co,

sentifi.com

Market voices on:

Powered by GET.comGetCom